Home > News

News

(1) Hospira UK Ltd (2) Generics (UK) Ltd (t/a Mylan) v Novartis AG [2013] EWCA Civ 166311 December 2013Michael Tappin QC  recently appeared with Tom Mitcheson for Hospira and Generics, the successful respondents to an appeal brought by Novartis against the invalidation of one of its patents. Novartis’ patent related to the use of a particular member of the bisphosphonate class of drugs, zoledronate. Claim 7 claimed the use of zoledronate for the […]
IPC Media Ltd v Media 10 [2013]EWHC 3796 (IPEC)6 December 2013James Mellor QC and Jessie Bowhill recently acted for the successful defendant in IPC Media Ltd v Media 10. The claimant was the owner of the well known IDEAL HOME magazine and the defendant ran the IDEAL HOME SHOW. The parties (or their predecessors) had co-existed in the market for almost 100 years. The claimant […]
Taylor v Maguire [2013] EWHC 3804 (IPEC)3 December 2013Ashton Chantrielle recently appeared for the Claimant artist in a copyright infringement case in the IP Enterprise Court. The Claimant was a paper artist running an online business making and selling paper cuttings. It was alleged that the Defendant had infringed copyright in those works by creating, replicating, possessing and dealing in works, which replicated […]
Actavis UK Ltd. & Ors v Eli Lilly & Co [2013] EWHC 3749 (Pat)30 November 2013Isabel Jamal recently appeared with Thomas Raphael for Actavis UK Ltd., the successful respondent to an application by Eli Lilly (“Lilly”) for stays on the basis of alleged abuse of process, against certain actions initiated by Actavis for declarations of non-infringement of the Lilly’s patents. The dispute between the parties relates to four actions in […]
(1) Teva Pharma BV (2) Teva UK Lt v (1) Amgen Inc (2) Amgen Manufacturing Ltd [2013] EWHC 3711 (pat)21 November 2013James Abrahams recently appeared for Teva Pharma BV and Teva UK Ltd (“Teva”) resisting an application that the First Defendant (“AI”) cease to be a party to the proceedings issued by Teva. Proceedings had initially been issued against AI alone as the registered proprietor of the European patent in issue. AI had however assigned the […]